Ketorolac in neonates and infants following congenital heart surgery: a retrospective review.

Amy L KiskaddonArabela C StockJamie L FiersteinAlexandra MillerJames A QuintessenzaNeil Goldenberg

Published in: Cardiology in the young (2023)

If validated prospectively, these findings suggest that a ketorolac regimen 0.5 mg/kg/dose every 6 hours in neonates and infants post-cardiac surgery may be safe with regard to renal function and bleeding risk, and effective regarding opioid-sparing capacity.

Keyphrases

cardiac surgery
low birth weight
minimally invasive
acute kidney injury
coronary artery bypass
chronic pain
pain management
atrial fibrillation
robot assisted
preterm infants
acute coronary syndrome
preterm birth
percutaneous coronary intervention